Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar

Michael Patrick Doyle speaks on current updates of litigation against the Boehringer Ingelheim drug Pradaxa.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The current state of this litigation is important for plaintiff attorneys due to future ramifications.

Houston, TX (PRWEB) September 27, 2013

Doyle Raizner LLP partner Michael Patrick Doyle is speaking at American Association for Justice’ (AAJ) Pharmaceutical and Medical Device Ligation Update in Philadelphia. The CLE opportunity is exclusively for plaintiff trial lawyers.

Doyle is presenting updates on the current state of litigation against the Boehringer Ingelheim drug Pradaxa. The makers of Pradaxa are accused of alleged negligence, aggressive marketing tactics and other charges due to the number of fatalities and serious injuries linked to the drug. Pradaxa is an anticoagulant prescribed for patients with atrial fibrillation. The issue with Pradaxa allegedly lies in the lack of antidote and the inability to reverse the drug’s side effects of uncontrolled bleeding (Master Case File 3:12-md-02385-DRH-SCW Southern District of Illinois).

Litigation has been centralized in the Southern District of Illinois before Chief Judge David R Herndon. Judge Herndon has experience with large multidistrict pharmaceutical litigation. There are currently 1,488 cases filed in the MDL (MDL 2385).

“The current state of this litigation is important for plaintiff attorneys due to future ramifications. This is a drug the FDA not only approved but also fast tracked. It remains to be seen if it will remain a viable alternative to more established and safer medications,” Doyle said.

AAJ is the largest trial bar association in the world. The group’s members include attorneys, law professors, paralegals, and law students all working to serve clients successfully and protect the democratic values inherent in the civil justice system. The group’s mission is to “promote a fair and effective justice system.”

Doyle Raizner LLP is a national trial law firm with offices in Houston and Phoenix. The firm’s practice areas include pharmaceutical and medical device injuries, toxic torts, workers’ compensation bad faith and catastrophic personal injury.

Michael Patrick Doyle is a personal injury lawyer, board certified in personal injury law by the Texas Board of Legal Specialization. He focuses much of his practice on working with victims of pharmaceutical and medical device negligence and other mass torts. Doyle champions the rights of those who have been injured or wronged, with a strong track record of recovering damages for victims and their families. He can be contacted at:

Doyle Raizner LLP
1221 McKinney Suite 4100
Houston, TX 77010
713-571-1146
http://www.pradaxalitigation.com


Contact